Diversity In Coronavirus Vaccine Trials Demanded From Drug Companies

There are growing demands that drugmakers and investigators ensure diversity in coronavirus vaccine trials by including racial minorities, older people and those with underlying medical conditions.

Comments

Popular posts from this blog

FIVE SIGNS YOUR TEEN MAY NEED TO BE EVALUATED FOR DEPRESSION

6 TIPS TO ESTABLISHING & MAINTAINING BREASTMILK SUPPLY WITH A NEWBORN

GETTING BACK TO SCHOOL SAFELY